NCT06629259View on ClinicalTrials.gov

Guanfacine for Alcohol Use Disorder (AUD)

PHASE2RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

August 31, 2029

Study Completion Date

September 7, 2029

Conditions
Alcohol Use Disorder
Interventions
DRUG

Guanfacine Extended Release (XR)

3mg tablet once daily

DRUG

Placebo

placebo tablet once daily

Trial Locations (2)

46202

RECRUITING

The Stark Neuroscience Building (Goodman Hall), Indianapolis

07107

RECRUITING

Rutgers School of Health Professionals, Newark

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Indiana University

OTHER

NCT06629259 - Guanfacine for Alcohol Use Disorder (AUD) | Biotech Hunter | Biotech Hunter